VC-backed Avidity Biosciences debuts IPO

La Jolla, California-based Avidity Biosciences, a biotechnology company, has raised $259.2 million for its IPO after pricing its 14.4 million shares at $18 per share.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this